Skip to content

Erlotinib 13C6 Hydrochloride

Erlotinib 13C6 Hydrochloride

Product Description
CAT No.
ALN-E018D04
CAS No.
1210610-07-3
Mol. F.
C1613C6H23N3O4 : HCl
Mol. Wt.
399.4 : 36.5
Stock
Please Inquire
Chemical Name : N-(3-Ethynylphenyl-1,2,3,4,5,6-13C6)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine hydrochloride
Smiles : C#C[13C]1=[13CH][13CH]=[13CH][13C](NC2=NC=NC3=C2C=C(OCCOC)C(OCCOC)=C3)=[13CH]1.Cl
Inchi : InChI=1S/C21H14O6/c1-9(22)10-6-7-11-13(8-10)20(25)16-17(18(11)23)21(26)15-12(19(16)24)4-3-5-14(15)27-2/h3-8,23,25H,1-2H3

Erlotinib in combination with capecitabine and docetaxel in patients with metastatic breast cancer: A dose-escalation study

Chris Twelvesa, Joseu00b4 M. Trigob , Rob Jonesc , Flavio De Rosad , Ashok Rakhite , Scott Fettnere , Tonya Wrightc , Joseu00b4 BaselganEuropean journal of cancer 44 (2008) 419 u2013 426

Development and validation of a stability indicating HPLC method for the quantification of impurities in Erlotinib hydrochloride dosage forms

BabuC1, Narasimha\xa0 RaoK.L1,\xa0 DevannaN1, Suresh Reddy\xa0 K.V.N – Solubility Measurement and Correlation of Two Erlotinib Hydrochloride Polymorphs in Alcohols and Ketones from 273.15 to 323.15 K

Jinghuan Zhai, Junrui Zhao, Zhenzhen Chen, Changwei Xiao, Xijian Liu, Lijuan Zhang, and Jie Lu

J. Chem. Eng. Data 2017, 62, 1, 516–524 – Separation and Determination of Process-Related Impurities of Erlotinib Using Reverse-Phase HPLC with a Photo-Diode Array Detector

Request For Quotation